However, there is no doubt about its potential as a therapeutic option in HCC, due to the strong pro-tumorigenic effects that TGF-β might mediate at later stages in the tumor cell and at all the stages in the liver tumor stroma. Here, TGFB1 is linked to hepatocellular carcinoma.